Avicanna Inc. (OTC:AVCNF – Get Free Report) shares fell 9.9% during mid-day trading on Monday . The company traded as low as $0.20 and last traded at $0.20. 13,200 shares were traded during mid-day trading, a decline of 24% from the average session volume of 17,369 shares. The stock had previously closed at $0.23.
Avicanna Price Performance
The firm’s 50-day moving average is $0.21 and its 200-day moving average is $0.24.
Avicanna Company Profile
Avicanna Inc, a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets worldwide. It commercializes approximately thirty proprietary evidence-based finished products.
Recommended Stories
- Five stocks we like better than Avicanna
- Pros And Cons Of Monthly Dividend Stocks
- Dow Jones: A Relevant Benchmark or a Relic of the Past?
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- 3 Big-Name Stocks Just Announced Big-Time Dividend Increases
- Business Services Stocks Investing
- Market Overreaction: 2 Stocks to Buy on the Way Down
Receive News & Ratings for Avicanna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avicanna and related companies with MarketBeat.com's FREE daily email newsletter.
